Cellular Longevity, Inc. — Form D
Cellular Longevity, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2024-03-29. The offering totals $76.3M, of which $76.3M was reported sold. Industry: Other Technology.
Offering
- Filed: 2024-03-29
- Form: D
- Accession: 0001799919-24-000003
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $76.3M
- Amount sold: $76.3M
- Investors: 38
- Date of first sale: 2024-03-05
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-509102
Issuer
- Name: Cellular Longevity, Inc.
- CIK: 0001799919
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 548 MARKET STREET, SUITE #26099, SAN FRANCISCO, CA, 94104
- Phone: 408-757-0450
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Laura Deming | Director | San Francisco, CA |
| Linda Rhodes | Director | San Francisco, CA |
| Celine-Lea Halioua-Haubold | Director | San Francisco, CA |
| Celine-Lea Halioua-Haubold | Executive Officer | San Francisco, CA |
| Kevin Zhang | Director | Los Angeles, CA |
| Blake Scholl | Director | San Francisco, CA |
Other filings by this issuer (5)
More